QQ客服 官方微博 反馈留言

	The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma
	Gong, Jifang; Hu, Bing; Zhang, Xiaotian; Zhang, Fengchun; Zhang, Jun; Xu, Nong e; Fan, Qingxia; Bai, Yuxian; Jiao, Shunchang; Wang, Jinwan
刊名	ONCOLOGIST
	2014
卷号	19期号:2
ISSN号	1083-7159
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4884870
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Gong, Jifang,Hu, Bing,Zhang, Xiaotian,et al. The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma[J]. ONCOLOGIST,2014,19(2).
APA	Gong, Jifang.,Hu, Bing.,Zhang, Xiaotian.,Zhang, Fengchun.,Zhang, Jun.,...&Shen, Lin.(2014).The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma.ONCOLOGIST,19(2).
MLA	Gong, Jifang,et al."The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma".ONCOLOGIST 19.2(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。